Section one: Contracting authority
one.1) Name and addresses
NHS Supply Chain Operated by Health Solutions Team Limited acting as agent of Supply Chain Coordination Ltd (SCCL)
c/o Skipton House, 80 London Road,
London
SE1 6LH
Contact
Alexandra Gothard
alexandra.gothard@supplychain.nhs.uk
Country
United Kingdom
NUTS code
UKI4 - Inner London – East
Internet address(es)
Main address
https://www.gov.uk/government/organisations/department-of-health
Buyer's address
https://www.gov.uk/government/organisations/department-of-health/about/procurement
one.1) Name and addresses
Health Solutions Team Limited,
Foxbridge Way, Normanton, United kingdom
Normanton
WF6 1TL
Contact
Alexandra Gothard
alexandra.gothard@supplychain.nhs.uk
Telephone
+44 7929018002
Fax
+44 1924328744
Country
United Kingdom
NUTS code
UKE45 - Wakefield
Internet address(es)
Main address
https://www.gov.uk/government/organisations/department-of-health
Buyer's address
https://www.gov.uk/government/organisations/department-of-health/about/procurement
one.2) Information about joint procurement
The contract involves joint procurement
The contract is awarded by a central purchasing body
one.3) Communication
Additional information can be obtained from the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
https://nhssupplychain.app.jaggaer.com/
one.4) Type of the contracting authority
National or federal Agency/Office
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Neuromodulation Devices Consumables and Associated Products 2023
two.1.2) Main CPV code
- 33158210 - Stimulator
two.1.3) Type of contract
Supplies
two.1.4) Short description
Non-exclusive Framework Agreement (FAG) for the supply to the NHS Supply Chain customer base via the E-Direct Route. Product range to include, but not limited to stimulation of; Deep Brain, Spinal Cord, Sacral Nerve, Vagal Nerve, Dorsal Route ganglion, Peripheral Nerve, Radio Frequency Pain Management, Intrathecal Brug Delivery Pumps and Dorsal Ramus Medial Branch nerve that meet the requirements of users and patients. The FAG will provide access to Neuromodulation Devices/Consumables that are associated with Neuromodulation procedures.
Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £187,484,968.00 for the initial term of FAG, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the FAG. The estimated value over the total FAG term (including any extension options) is £457,463,323.00
two.1.5) Estimated total value
Value excluding VAT: £457,463,323
two.1.6) Information about lots
This contract is divided into lots: Yes
Maximum number of lots that may be awarded to one tenderer: 1
The contracting authority reserves the right to award contracts combining the following lots or groups of lots:
1
two.2) Description
two.2.1) Title
Neuromodulation Devices, Consumables and Associated Products
Lot No
Lot 1
two.2.2) Additional CPV code(s)
- 31711140 - Electrodes
- 33141200 - Catheters
- 33158210 - Stimulator
- 42122410 - Pumps for medical use
two.2.3) Place of performance
NUTS codes
- UKE45 - Wakefield
Main site or place of performance
Foxbridge Way
Normanton
United Kingdom
WF6 1TL
two.2.4) Description of the procurement
Neuromodulation Product range to include, but not limited to the supply of; Deep Brain; Spinal cord, Sacral Nerve, Vagal Nerve, Dorsal Route ganglion, Peripheral Nerve, Radio Frequency Pain Management, Intrathecal Brug Delivery Pumps and Dorsal Ramus Medial Branch nerve.
two.2.14) Additional information
Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £84.5m to £86m in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.
two.3) Estimated date of publication of contract notice
10 August 2022
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
Section six. Complementary information
six.3) Additional information
The following certification will be a requirement of the upcoming tender exercise and Applicants may be required to include evidence of this with their tender submission.
ISO9001:2015 accredited by the UKAS (or equivalent) to cover all segments of the Applicant’s and the product’s supply chain. This should include, but not be limited to, manufacturing, storage and distribution. Further information in respect of certification requirements will be set out in the notice for the forthcoming procurement. If such certificates are not in the name of the Applicant then the Applicant must supply a copy of agreements setting out the authority and responsibilities of all parties in the supply chain.
The purpose of this notice is to draw attention to a procurement that NHS Supply Chain intends to commence during the subsequent 12 months. The invitation to tender will be the subject of a separate notice and it is that notice to which potential suppliers will need to respond at the appropriate time.
The Framework Agreement between NHS Supply Chain and successful suppliers will reserve the right to purchase the same or similar supplies and/or services from suppliers not appointed to the Framework Agreement at its sole discretion.
NHS Supply Chain expects to provide successful suppliers with the opportunity to offer additional savings to customers through the provision of discounted pricing, value added offerings and commitment/bulk buy initiatives.
Framework Agreement will be between NHS Supply Chain and the Supplier, however 1) NHS Supply Chain, 2) any NHS Trust; 3) any other NHS entity; 4) any government department, agency or other statutory body and/or 5) any private sector entity active in the UK healthcare sector will be able to enter into a direct contract with the Supplier for any of the supplies and/or services under the Framework.
The NHS adopted PPN 06/20 (taking account of Social Value in the award of Government Contracts) from April 2022. As such all NHS SC Contracts going out to market after this date will include Social Value weighting. Therefore the future contract for Neuromodulation Devices & Associated Products 2023 will include some qualitative evaluation questions on Social Value with a minimum weighting of 10% towards the award. We would like to engage with the market in the pre-tender phase to communicate what social value is but also to understand what the market may be capable of delivering.
As part of its pre-tender strategy, NHS Supply Chain would also like to engage with suppliers of these products via a Request for Information (RFI). If you would like to complete the RFI in respect of the products which are the subject of this procurement then please follow the below instructions;
Portal Dashboard
SQs Open to All Suppliers
Select the link SQ_179 RFI Neuromodulation Devices Consumables and Associated Products 2023 (Project Code_1009)
Select ‘my response’ tab, Complete Questionnaire and submit.
Candidates wishing to complete the RFI must first register their expression of interest on Jaggaer via the following URL: https://nhssupplychain.app.jaggaer.com/.
If you are not already registered, complete the registration process first to allow access to express interest in this opportunity. Applicants will then have until the 27th April 27/04/22 to complete and return the RFI document, which includes some sustainability questions aligned to Social Value. Candidates are encouraged to download the Supplier Handbook located within the eProcurement portal by following the 'Supplier Help centre' link within the Useful Links section of the Dashboard.